Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer

Anticancer Research

Volumn 22, Issue 6 C, 2002, Pages 4291-4296

  Nakayama, Yoshifumi ^a   Nagashima, Nobuo ^a   Minagawa, Noritaka ^a   Inoue, Yuzuru ^a   Katsuki, Takefumi ^a   Onitsuka, Koji ^a   Sako, Tatsuhiko ^a   Hirata, Keiji ^a   Nagata, Naoki ^a   Itoh, Hideaki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Colorectal cancer; Tumor associated macrophage

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN;

ADULT; AGED; CANCER RECURRENCE; CLINICAL ARTICLE; COLORECTAL CANCER; CONFERENCE PAPER; DENSITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROVESSEL DENSITY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; STROMA; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 0036875779     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Gravas DT and Valente AJ: Monocyte chemotactic proteins from human tumor cells. Biochem Pharmacol 41: 333-337, 1991.
2. Mantovani A: Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71: 5-16, 1994.
3. Alleva DG, Burger CJ and Elgert KD: Tumor-induced regulation of supressor macrophge nitric oxide and TNF-α production. J Immunol 153: 1674-1686, 1994.
4. Steege JT, Buurman W, Arends JW and Forget P: Presence of inducible nitric oxide synthase, nitrotytosine, CD68, and CD34 in the small intestine in celiac disease. Lab Invest 77: 29-36, 1997.
5. DiNapoli MR, Calderon CL and Lopez DM: The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J Exp Med 183:1323-1329, 1996.
6. Kono K, Salazar-Onfray F, Petersson M, Hansson J, Massucci G, Wasserman K, Nakazawa T, Anderson P and Kiessling R: Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing ξ molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity. Eur J Immunol 26: 1308-1313, 1996.
7. Ohmori T, Okada K, Arita N, Watanabe Y and Tabei R: Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinoma. Histol Histopathol 10: 789-794, 1995.
8. Alleva DG, Askew D, Burger CJ and Elgert KD: Fibrosarcoma-induced increase in macrophage tumor necrosis factor a synthesis supressor T cell response. J Leukocyte Biol 54: 152-160, 1993.
9. Hildenbrand R, Jansen C, Wolf G, Böhme B, Berger S, Minchwitz GV, Hrölin A, Kaufman M and Stutte HJ: Transforming growth factor-β stimulates urokinase expression in tumor-associated macrophage of the breast. Lab Investg 78: 59-71, 1998.
10. Alleva DG, Walker TM and Elgert KD: Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-β1: contrasting effects on resting and activated macrophages. J Leukocyte Biol 57: 919-928, 1995.
11. Bonta IL and Ben-Efraim S: Involvement of inflammatory mediators in macrophage antitumor activity. J Leukocyte Biol 54: 613-626, 1993.
12. Oghiso Y, Yamada Y, Ando K, Ishihara H and Shibata YA: Differential induction of prostaglandin E2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF. J Leukocyte Biol 53: 86-92, 1993.
13. Eerika AK, Soini Y and Paakko P: A high number of tumor-infiltrating lymphocytes associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res 6: 1875-1881, 2000.
14. Norazmi MN, Hohmann AW, Skinner JM, Jarvis LR and Braadley J: Density and phenotype of tumor-associated mononuclear cells in colonic carcinomas determined by computer-assisted video image analysis. Immunology 69: 282-286, 1990.
15. Ohtani H: Stromal reaction in cancer tissue: Pathphysiologic significance of the expressionof matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions. Pathol Int 48: 1-9, 1998.
16. Ohashi Y, Ishibashi S, Suzuki T, Shineha R, Moriya T, Satomi S and Sasano H: Significance of tumor-associated tissue eosinophilia and other inflammatory cell infiltrate in early esophageal squamous cell carcinoma. Anticancer Res 20: 3025-3030, 2000.
17. Fiumara A, Belfiore A, Russo G, Salomone E, Santonocito GM, Ippolito O, Vingeri R and Gangemi P: In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer. J Clin Endocrinol Metab 82: 1615-1620, 1987.
18. Ma Y, Xian M, Li J, Kawabata T and Okada S: Interrelations of clinicopathological variable, local immune response and prognosis in esophageal squamous cell carcinoma. APMIS 107: 514-522, 1999.
19. Toomey D, Hermey J, Condron C, Kay E and Bouchier-Hayes D: Phenotyping of immune cell infiltrates in breast and colorectal tumors. Immunol Invest 28: 29-41, 1999.
20. Takanami I, Takeuchi K and Kodaira: Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: Association with angiogenesis and poor prognosis. Oncology 57: 138-142, 1999.
21. Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N and Nomura Y: Prognostic value of tumor-associated macrophage count in human bladder cancer. Iht J Urology, 7: 263-269, 2000.
22. Lissbrant IF, Stattin P, Wikström P, Damber J-E, Egevad L and Bergh A: Tumor-associated macrophages in human prostate cancer: relation to clinicopathological variable and survival. Int J Oncol 17: 445-451, 2000.
23. Heidl G, Davaris P, Zwadlo G, Jagoda MS, Düchting S, Bierhoff E, Güter T, Krieg V and Sorg C: Association of macrophages detected with monoclonal antibody 25F9 with progression and pathobiological classification of gastric carcinoma. J Cancer Res Clin Oncol 113: 567-572, 1987.
24. Hashimoto I, Kodama J, Seki N, Hongo A, Miyagi Y, Yoshinouchi M and Kudo T: Macrophage infiltration and angiogenesis in endometrial cancer. Anticancer Res 20: 4853-4856, 2000.
25. Matsumura M, Chiba Y, Lu C, Amaya H, Shimomatsuya T, Horiuchi T, Muroaka R and Tanigawa: Platlet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with angiogeneisis and macrophage infiltration in colorectal cancer. Cancer Letters 128: 55-63, 1998.
26. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Eng J Med 324: 18, 1991.
27. Pretlow TP, Keith EF, Cryar AK et al: Eosinophil infiltration of human colonic carcinoma as a prognostic indicator. Cancer Res 43: 2997-3000, 1983.
28. Fisher ER, Paik SM, Rockette H, Jones J, Caplan R and Fisher B: Prognostic significance of eosinophils and mast cells in rectal cancer. Human Pathol 20: 159-163, 1989.
29. Jass JR, Love SB and Northover JMA: A new prognostic classification of rectal cancer. Lancet 329: 1303-1306, 1987.
30. Harrison JC, Dean PJ, El-Zeky F and Zwaag RV: Impact of the Crohn's-like lymphoid reaction of staging of right-sided colon cancer. Hum Pathol 26: 31-38, 1995.
31. Underweed JCE: Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. Br J Cancer 30: 538-548, 1974.
32. Shimokawara I, Imamura M, Yamanaka N, Ishii Y and Kikuchi K: Identificationof lymphocyte subpopulations in human breast cancer tissue and its significance: and immunoperoxidase study with anti-human T- and B-cell sera. Cancer 49: 1456-1464, 1982.
33. Jass JR: Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 39: 585-589, 1986.
34. Minamoto T, Mai M, Watanabe K, Ooi A, Kitamura T, Takahashi Y, Ueda H, Ogino T and Nakanishi I: Medullary carcinoma with lymphocytic infiltration of the stomach. Clinicopathologic study of 27 cases and immunohistochemical analysis of the subpopulations of infiltrating lymphocytes in tumor. Cancer 66: 945-952, 1990.
35. Ropponen MK, Eskelinen MJ, Lipponen RK, Alhava E and Kosma VM: Prognostic value of tumor-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182: 318-324, 1997.
36. Fiocchi C and Finke JH: Tumor-infiltrating lymphocytes: new hopes. Gastroenterology 98: 531-534, 1990.
37. Shimura S, Yang G, Ebara S, Wheeler TM, Frolov A and Thompson TC: Reduced infiltration of tumor-associated macrophages in human prostate cancer: Association with cancer progression. Cancer Res 60: 5857-5861, 2000.
38. Mantovani A, Bottazzi B, Govoni D, Colotta F, Sozzoni S and Ruco L: Origin and function of tumor-associated macrophages. Immunology Today 13: 265-270, 1992.
39. North RJ: The concept of the activated macrophage. J Immunol 121: 806-809, 1978.
40. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J and Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996.